The role of core TNF/LIGHT family members in lymph node homeostasis and remodeling

Immunological Reviews

Volumn 244, Issue 1, 2011, Pages 75-84

  Zhu, Mingzhao ^a   Fu, Yang Xin ^b  

^a INSTITUTE OF BIOPHYSICS   (China)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

B cells; Cell trafficking; Dendritic cells; Endothelial cells

Indexed keywords

CYTOKINE; GLYCOPROTEIN D; HERPESVIRUS ENTRY MEDIATOR LIGAND; LYMPHOTOXIN; LYMPHOTOXIN ALPHA BETA; LYMPHOTOXIN BETA RECEPTOR; TUMOR NECROSIS FACTOR; VASCULOTROPIN;

B LYMPHOCYTE; CANCER IMMUNOTHERAPY; ENDOTHELIUM CELL; HERPES SIMPLEX VIRUS; HOMEOSTASIS; HUMAN; INFECTION; LYMPH NODE; METASTASIS; NEOPLASM; ORGANOGENESIS; PLASTICITY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VACCINATION;

ANIMALS; B-LYMPHOCYTES; BLOOD VESSELS; CELL MOVEMENT; CELLULAR MICROENVIRONMENT; DENDRITIC CELLS; ENDOTHELIAL CELLS; GENE EXPRESSION; HOMEOSTASIS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; LYMPH NODES; LYMPHATIC VESSELS; LYMPHOTOXIN ALPHA1, BETA2 HETEROTRIMER; MICE; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 14; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80054875663     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.2011.01061.x     Document Type: Review

References (63)

1. Drayton DL, Liao S, Mounzer RH, Ruddle NH. Lymphoid organ development: from ontogeny to neogenesis. Nat Immunol 2006;7:344-353.
2. von Andrian UH, Mempel TR. Homing and cellular traffic in lymph nodes. Nat Rev Immunol 2003;3:867.
3. McConnell I, Hopkins J. Lymphocyte traffic through antigen-stimulated lymph nodes. I. Complement activation within lymph nodes initiates cell shutdown. Immunology 1981;42:217-223.
4. Webster B, Ekland EH, Agle LM, Chyou S, Ruggieri R, Lu TT. Regulation of lymph node vascular growth by dendritic cells. J Exp Med 2006;203:1903-1913.
5. Angeli V, et al. B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 2006;24:203-215.
6. Martin-Fontecha A, et al. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J Exp Med 2003;198:615-621.
7. Soderberg KA, Payne GW, Sato A, Medzhitov R, Segal SS, Iwasaki A. Innate control of adaptive immunity via remodeling of lymph node feed arteriole. Proc Natl Acad Sci USA 2005;102:16315-16320.
8. Rot A, von Andrian UH. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 2004;22:891-928.
9. Katakai T, Hara T, Sugai M, Gonda H, Shimizu A. Lymph node fibroblastic reticular cells construct the stromal reticulum via contact with lymphocytes. J Exp Med 2004;200:783.
10. Bajenoff M, Egen JG, Qi H, Huang AYC, Castellino F, Germain RN. Highways, byways and breadcrumbs: directing lymphocyte traffic in the lymph node. Trends Immunol 2007;28:346.
11. Carl FW. Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways. Immunol Rev 2008;223:186-201.
12. Wang Y, Zhu M, Miller M, Fu YX. Immunoregulation by tumor necrosis factor superfamily member LIGHT. Immunol Rev 2009;229:232-243.
13. Ware CF. Network communications: lymphotoxins, LIGHT, and TNF. Annu Rev Immunol 2005;23:787-819.
14. Liao S, Ruddle NH. Synchrony of high endothelial venules and lymphatic vessels revealed by immunization. J Immunol 2006;177: 3369-3379.
15. Banks TA, et al. A lymphotoxin-IFN-β axis essential for lymphocyte survival revealed during cytomegalovirus infection. J Immunol 2005;174:7217-7225.
16. Fu YX, Chaplin DD. Development and maturation of secondary lymphoid tissues. Annu Rev Immunol 1999;17:399-433.
17. Mebius RE. Organogenesis of lymphoid tissues. Nat Rev Immunol 2003;3:292.
18. Ansel KM, Cyster JG. Chemokines in lymphopoiesis and lymphoid organ development. Curr Opin Immunol 2001;13:172.
19. Lee Y, et al. Recruitment and activation of naive T cells in the islets by lymphotoxin β receptor-dependent tertiary lymphoid structure. Immunity 2006;25:499.
20. Wang J, et al. The complementation of lymphotoxin deficiency with LIGHT, a newly discovered TNF family member, for the restoration of secondary lymphoid structure and function. Eur J Immunol 2002;32:1969-1979.
21. Chyou S, et al. Fibroblast-type reticular stromal cells regulate the lymph node vasculature. J Immunol 2008;181:3887-3896.
22. Browning JL, et al. Lymphotoxin-beta receptor signaling is required for the homeostatic control of HEV differentiation and function. Immunity 2005;23:539-550.
23. Stopfer P, Mannel DN, Hehlgans T. Lymphotoxin-β receptor activation by activated T cells induces cytokine release from mouse bone marrow-derived mast cells. J Immunol 2004;172:7459-7465.
24. Zhu M, Yang Y, Wang Y, Wang Z, Fu Y-X. LIGHT regulates inflamed draining lymph node hypertrophy. J Immunol 2011;186:7156-7163.
25. Kataru RP, et al. Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood 2009;113:5650-5659.
26. Halin C, Tobler NE, Vigl B, Brown LF, Detmar M. VEGF-A produced by chronically inflamed tissue induces lymphangiogenesis in draining lymph nodes. Blood 2007;110:3158-3167.
27. Schneider K, Potter KG, Ware CF. Lymphotoxin and LIGHT signaling pathways and target genes. Immunol Rev 2004;202:49-66.
28. Dejardin E, et al. The lymphotoxin-β receptor induces different patterns of gene expression via two NF-κB pathways. Immunity 2002;17:525.
29. Cavender DE, Edelbaum D, Ziff M. Endothelial cell activation induced by tumor necrosis factor and lymphotoxin. Am J Pathol 1989;134:551-560.
30. Madge LA, Kluger MS, Orange JS, May MJ. Lymphotoxin-{alpha}1{beta}2 and LIGHT induce classical and noncanonical NF-κB-dependent proinflammatory gene expression in vascular endothelial cells. J Immunol 2008;180:3467-3477.
31. Ansel KM, et al. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 2000;406:309.
32. Galli SJ, Grimbaldeston M, Tsai M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol 2008;8:478-486.
33. McLachlan JB, et al. Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nat Immunol 2003;4:1199-1205.
34. Scheu S, Alferink J, Potzel T, Barchet W, Kalinke U, Pfeffer K. Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin β in mesenteric lymph node genesis. J Exp Med 2002;195:1613-1624.
35. Kang HS, et al. Signaling via LTβR on the lamina propria stromal cells of the gut is required for IgA production. Nat Immunol 2002;3:576-582.
36. Yoneyama H, et al. Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs. J Exp Med 2005;202:425-435.
37. Shaikh RB, et al. Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction. J Immunol 2001;167:6330-6337.
38. Wang J, et al. The regulation of T cell homeostasis and autoimmunity by T cell-derived LIGHT. J Clin Invest 2001;108: 1771-1780.
39. Tamada K, et al. LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J Immunol 2000;164:4105-4110.
40. Merad M, Ginhoux F, Collin M. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat Rev Immunol 2008;8:935-947.
41. Nagao K, et al. Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions. Proc Natl Acad Sci USA 2009;106:3312-3317.
42. Jung S, et al. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 2002;17:211.
43. Kimber I, Cumberbatch M. Stimulation of Langerhans cell migration by tumor necrosis factor α (TNF-α). J Invest Dermatol 1992;99:48S-50S.
44. Valladeau J, et al. The monoclonal antibody DCGM4 recognizes Langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surface. Eur J Immunol 1999;29:2695-2704.
45. Kissenpfennig A, et al. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 2005;22:643.
46. Randolph GJ, Ochando J, Partida-Sanchez S. Migration of dendritic cell subsets and their precursors. Annu Rev Immunol 2008;26:293-316.
47. Grabbe S, Steinbrink K, Steinert M, Luger TA, Schwarz T. Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity. J Immunol 1995;155:4207-4217.
48. van de Pavert SA, Mebius RE. New insights into the development of lymphoid tissues. Nat Rev Immunol 2010;10:664-674.
49. Tumanov AV, et al. Dissecting the role of lymphotoxin in lymphoid organs by conditional targeting. Immunol Rev 2003;195:106-116.
50. Randall TD, Carragher DM, Rangel-Moreno J. Development of secondary lymphoid organs. Annu Rev Immunol 2008;26:627.
51. Kumar V, et al. Global lymphoid tissue remodeling during a viral infection is orchestrated by a B cell-lymphotoxin-dependent pathway. Blood 2010;115:4725-4733.
52. Kim M-Y, et al. Neonatal and adult CD4+CD3- cells share similar gene expression profile, and neonatal cells up-regulate OX40 ligand in response to TL1A (TNFSF15). J Immunol 2006;177:3074-3081.
53. Kim M-Y, et al. Function of CD4+CD3- cells in relation to B- and T-zone stroma in spleen. Blood 2007;109:1602-1610.
54. Ivanov I, Diehl G, Littman D. Lymphoid tissue inducer cells in intestinal immunity. In: Honjo T, Melchers F eds. Gut-Associated Lymphoid Tissue. Berlin: Springer, 2006:59-82.
55. Kunder CA, et al. Mast cell-derived particles deliver peripheral signals to remote lymph nodes. J Exp Med 2009;206:2455-2467.
56. Gretz JE, Norbury CC, Anderson AO, Proudfoot AEI, Shaw S. Lymph-borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex. J Exp Med 2000;192:1425-1440.
57. Kneilling M, et al. Direct crosstalk between mast cell-TNF and TNFR1-expressing endothelia mediates local tissue inflammation. Blood 2009;114:1696-1706.
58. Saharinen P, Tammela T, Karkkainen MJ, Alitalo K. Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol 2004;25:387.
59. Tammela T, Alitalo K. Lymphangiogenesis: molecular mechanisms and future promise. Cell 2010;140:460-476.
60. Harrell MI, Iritani BM, Ruddell A. Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. Am J Pathol 2007;170:774-786.
61. Ellis LM, Hicklin DJ. VEGF-targeted therapy: mechanisms of anti-tumour activity. Nat Rev Cancer 2008;8:579.
62. Bergers G, Hanahan D. Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 2008;8:592.
63. Kataru RP, et al. T lymphocytes negatively regulate lymph node lymphatic vessel formation. Immunity 2011;34:96-107.